(Q46800361)

25 December 2017

title

PET is better than perfusion SPECT for early diagnosis of Alzheimer's disease -- for. (English)

1 reference

25 December 2017

0 references

Kazunari Ishii

1

1 reference

25 December 2017

Satoshi Minoshima

series ordinal

2

1 reference

25 December 2017

publication date

1 December 2005

1 reference

25 December 2017

number of pages

3

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

25 December 2017

volume

32

1 reference

25 December 2017

issue

12

1 reference

25 December 2017

page(s)

1463-1465

1 reference

25 December 2017

https://scigraph.springernature.com/pub.10.1007/s00259-005-1936-3

exact match

0 references

cites work

Mild cognitive impairment: Can FDG-PET predict who is to rapidly convert to Alzheimer's disease?

1 reference

https://api.crossref.org/works/10.1007%2FS00259-005-1936-3

MCI conversion to dementia and the APOE genotype: a prediction study with FDG-PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-005-1936-3

Cerebral glucose metabolism in patients with AD and different APOE genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-005-1936-3

Blinded clinical evaluation of positron emission tomography for diagnosis of probable Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-005-1936-3

APOE-dependent PET patterns of brain activation in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-005-1936-3

Alzheimer disease: improved visual interpretation of PET images by using three-dimensional stereotaxic surface projections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-005-1936-3

Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET.

21 January 2018

1 reference

12 December 2020

Metabolic interaction between ApoE genotype and onset age in Alzheimer's disease: implications for brain reserve

1 reference

12 December 2020

Direct comparison of spatially normalized PET and SPECT scans in Alzheimer's disease.

1 reference

12 December 2020

Tc-99m ethyl cysteinate dimer SPECT and 2-[F-18]fluoro-2-deoxy-D-glucose PET in Alzheimer's disease. Comparison of perfusion and metabolic patterns.

1 reference

12 December 2020

Altered PET functional brain responses in cognitively intact elderly persons at risk for Alzheimer disease (carriers of the epsilon4 allele)

1 reference

12 December 2020

Regional cerebral blood flow assessed with 99mTc-ECD SPET as a marker of progression of mild cognitive impairment to Alzheimer's disease.

1 reference

12 December 2020

Statistical brain mapping of 18F-FDG PET in Alzheimer's disease: validation of anatomic standardization for atrophied brains.

1 reference

12 December 2020

A diagnostic method for suspected Alzheimer's disease using H(2)15O positron emission tomography perfusion Z score

1 reference

12 December 2020

Brain 18F-FDG PET in the diagnosis of neurodegenerative dementias: comparison with perfusion SPECT and with clinical evaluations lacking nuclear imaging.

1 reference

12 December 2020

Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD.

1 reference

12 December 2020

Altered cerebral energy metabolism in Alzheimer's disease: a PET study.

1 reference

12 December 2020

Superiority of 3-dimensional stereotactic surface projection analysis over visual inspection in discrimination of patients with very early Alzheimer's disease from controls using brain perfusion SPECT.

1 reference

12 December 2020

Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease

1 reference

12 December 2020

Age at onset and regional cerebral glucose metabolism in Alzheimer's disease.

1 reference

12 December 2020

Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease.

1 reference

12 December 2020

Demonstration of decreased posterior cingulate perfusion in mild Alzheimer's disease by means of H215O positron emission tomography.

1 reference

12 December 2020

Diagnostic value of FDG-PET and HMPAO-SPET in patients with mild dementia and mild cognitive impairment: metabolic index and perfusion index

1 reference

12 December 2020

Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E.

1 reference

12 December 2020

Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study

1 reference

12 December 2020

High-resolution technetium-99m-HMPAO SPECT in patients with probable Alzheimer's disease: comparison with fluorine-18-FDG PET.

1 reference

12 December 2020

Differences of regional cerebral glucose metabolism between presenile and senile dementia of Alzheimer type

1 reference

12 December 2020

Cingulate cortex hypoperfusion predicts Alzheimer's disease in mild cognitive impairment

1 reference

12 December 2020

Differences in cerebral metabolic impairment between early and late onset types of Alzheimer's disease

1 reference

12 December 2020

HMPAO SPET and FDG PET in Alzheimer's disease and vascular dementia: comparison of perfusion and metabolic pattern.

1 reference

12 December 2020

10.1007/S00259-005-1936-3

Identifiers

DOI

1 reference

25 December 2017

1 reference

25 December 2017